New Acting Director Compounds Australia

Compounds Australia, through Therapeutic Innovation Australia (TIA), is part of the National Collaborative Research Infrastructure Strategy (NCRIS), a network of world-class research infrastructure facilities that drives and supports greater innovation in the Australian biomedical research sector and associated economic impact. Recently, CFBD CI Prof Sally-Ann Poulsen was appointed as acting Director of Compounds Australia. Curating Australia’s largest collection of compounds and natural products (~1.5M), Compounds Australia supports 38 national/international member organizations and >250 research projects annually, including the fragment screening campaigns of the CFBD. Monash University, University of Sydney and Griffith University are all member organizations. CFBD CI Prof Jonathan Baell is an existing Advisory Board Member of Compounds Australia. Many of the fragment libraries that are used by the Centre are currently managed by Compounds Australia. Congratulations to Sally-Ann on this excellent new role.